Alteration of the amniotic fluid and neonatal outcome

Acta Biomedica de l'Ateneo Parmense

Volumn 75, Issue SUPPL. 1, 2004, Pages 71-75

  Volante, Enrico ^a   Gramellini, Dandolo ^a   Moretti, Sabrina ^a   Kaihura, Christine ^a   Bevilacqua, Giulio ^a  

^a UNIVERSITY OF PARMA   (Italy)

Author keywords

Amniotic fluid; Oligohydramnios; Polyhydramnios

Indexed keywords

CYTOKINE; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 1; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; TUMOR NECROSIS FACTOR ALPHA;

AMNION FLUID ANALYSIS; CEREBRAL PALSY; CLINICAL ARTICLE; CONFERENCE PAPER; CYTOKINE PRODUCTION; DIAGNOSTIC VALUE; DIGESTIVE SYSTEM MALFORMATION; FEMALE; FETUS; FETUS DISEASE; HUMAN; HYDRAMNIOS; LEUKOMALACIA; LUNG HYPOPLASIA; NEUROLOGIC DISEASE; NEWBORN; NEWBORN CARE; OLIGOHYDRAMNIOS; PATHOPHYSIOLOGY; PREGNANCY COMPLICATION; PREMATURE FETUS MEMBRANE RUPTURE; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; SURGICAL MORTALITY; TREATMENT OUTCOME; URINARY TRACT MALFORMATION;

AMNIOTIC FLUID; FEMALE; HUMANS; OLIGOHYDRAMNIOS; POLYHYDRAMNIOS; PREGNANCY; PREGNANCY OUTCOME;

EID: 4043092075     PISSN: 03924203     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (14)

1. Panting-Kemp A, Nguyen T, Castro L. Substance abuse and polyhydramnios. Am J Obstet Gynecol 2002; 187-3: 602-5.
2. Panting-Kemp A, Nguyen T, Chang E, Quillen E, Castro L. Idiopathioc polyhydramnios and perinatal outcome. Am J Obstet Gynecol 1999; 181-5: 1079-82.
3. Banks EH, Miller DA. Perinatal risks associated with border line amniotic fluid index. Am J Obstet Gynecol 1999; 180-6: 1461-3.
4. Locatelli A, Vergani P, Di Pirro G, Doria V, Biffi A, Ghiaini A. Role of amnioinfusion in the management of premature rupture of membranes at <26 weeks' gestation. Am J Obstet Gynecol 2000; 183-4: 878-82.
5. Ogunyemi D, Thompson W. A case controlled of serial transabdominal amnioinfusions in the management of second trimester oligohydramnios due to premature rupture of membranes. Eur J Obstet Gynecol Reprod Biol 2002; 102-10: 167-72.
6. Gramellini D, Piantelli G, Delle Chiaie L, Rutolo S, Vadora E. Amnioinfusion in the management of oligoydramnios. J Perinat Med 1998; 26: 293-301.
7. Ludy JAM, Tbboel D, Rbben SGF, de Krijger RR, de Ridder MAJ, Wladimiroff JW. Prenatal prediction of pulmonary hypoplasia: Clinical, biotric, and Doppler velocity correlates. Pediatrics 2002; 109: 250-8.
8. Peruzzi L, Gianoglio B, Porcellini MG, Coppo R. Neonatal end stage renal failure associated with maternal ingestion of cyclo-oxygenase type 1 selective inhibitor Nimesulide as tocolytic. Lancet 1999; 354: 1610.
9. Norwood V, Morham SG, Smithies O. Post-natal development and progression of renal dysplasia in cyclo-oxygenase -2 null mice. Kidney Int 2000; 58: 2291-300.
10. Magnani C, Moretti S, Volante E, Bevilacqua G. Nimesulide ed insufficienza renale neonatale. La Pediatria Medica e Chirurgica 9° Congresso nazionale SIN Napoli 21/24 maggio 2003: 162.
11. Khanthou M, Fotopoulos S, Mouchtouri A, Lipsou N, Zika I, Sarafiudou J. Inflammatory mediators in perinatal asphyxia and infection. Acta Paedratr 2002; 448 (suppl): 92-7.
12. Yoon BH, Romero R, Park JS, et al. Fetal exposure to an intra-amniotc inflammation and development of cerebral palsy at the age of three years. Am J Obstet Gynecol 2000; 182: 675-81.
13. Gomez R, Romero R, Grezzi F, Yoon BH, Mazor M, Berry SM. The fetal inflammatory response syndrome. Am J Obstet Gynecol 1998; 179: 194-202.
14. Yoon BH, Park C-W, Chaiworapongsa T. Intauterine infection and development of cerebral palsy. BJOG 2003; 110 (20): 124-7.